
Neovasc NVCN
Geschäftsbericht 2021
hinzugefügt 23.12.2023
Neovasc Betriebsaufwand 2011-2026 | NVCN
Betriebsaufwand Jährlich Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 36.4 M | 31.6 M | 32.6 M | 34.8 M | 138 M | 24.7 M | 21.5 M | 11.1 M | 8.15 M | 5.82 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 138 M | 5.82 M | 34.4 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
2.19 B | $ 184.65 | 2.2 % | $ 13.8 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
121 M | $ 34.7 | 3.66 % | $ 1.6 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.44 | 0.97 % | $ 1.68 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.03 B | $ 290.0 | 0.64 % | $ 8.18 B | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.58 | -0.6 % | $ 36.1 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 40.53 | 3.79 % | $ 6.04 K | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.33 | 0.15 % | $ 125 M | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.5 | 0.51 % | $ 94 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.34 | 3.3 % | $ 293 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
40.3 M | $ 24.95 | - | $ 211 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Inogen
INGN
|
184 M | $ 6.56 | 1.71 % | $ 175 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | 0.97 % | $ 17.6 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Globus Medical
GMED
|
547 M | $ 93.82 | 0.9 % | $ 12.7 B | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.03 | -0.19 % | $ 1.23 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.34 | 1.4 % | $ 919 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.98 | 1.01 % | $ 71.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.04 | 0.56 % | $ 400 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.66 | 2.01 % | $ 382 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.74 | 1.44 % | $ 31 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 55.86 | 1.79 % | $ 1.64 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 39.17 | 1.85 % | $ 1.22 B | ||
|
LivaNova PLC
LIVN
|
697 M | $ 65.23 | 1.01 % | $ 3.56 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 88.7 | 1.11 % | $ 3.08 B | ||
|
FONAR Corporation
FONR
|
28.7 M | $ 18.7 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 78.25 | 0.17 % | $ 45.8 B |